Federal Register: FDA Delays Action on Certain Estrogen-Androgen Menopause Drugs to November 2026
August 28, 2026
August 28, 2026
WASHINGTON, Aug. 28 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) is extending the effective date of the notice published in the Federal Register on May 27, 2026, entitled "Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdraw . . .
* * *
The Food and Drug Administration (FDA) is extending the effective date of the notice published in the Federal Register on May 27, 2026, entitled "Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdraw . . .